Navigation Links
Inverness Medical Innovations to Pay April Series B Dividend in Additional Shares of Series B Stock
Date:3/19/2009

WALTHAM, Mass., March 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, intends to pay, to the extent declared, dividends payable April 15, 2009, on its Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB) in shares of Series B stock. Inverness will pay cash in lieu of any fractional shares resulting from the dividend.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Inverness Medical Innovations Agrees to Acquire Second Territory Rapid Diagnostics Business of ACON
2. Inverness Medical Innovations Announces Fourth Quarter 2008 Results
3. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
4. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
5. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
6. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
7. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
8. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
9. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
10. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
11. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Hanna Boys Center ... will be the keynote speaker at its second Professional Networking Breakfast on March ... which develops comprehensive strategies to create and expand opportunities for boys and young ...
(Date:2/21/2017)... ... , ... As recently as 2015, rhinoplasty was one of the Top 5 ... Some patients want to make a change in the appearance of their nose while ... The team at usrhinoplasty.org is expanding its article database to better inform ...
(Date:2/21/2017)... ... 2017 , ... Ray Insurance Agencies, a Dallas area firm providing asset protection ... on a six month charity event aimed at raising local support and donations that ... of the deadliest diseases in America; more than 7.5 million people die from cancer ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, ... medicine, will be launching its first bi-monthly issue of 2017 in February. The ... practice management, and One Health. , In making the announcement, American Veterinarian™ ...
(Date:2/21/2017)... Michigan (PRWEB) , ... February 21, 2017 , ... ... to the United States during Black History Month (officially African American History ... to many fields of American society of a diverse race of people, but ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets ... Devices - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:2/21/2017)... Research and Markets has announced the addition of the ... their offering. ... research Uterine cancer Drugs Price Analysis and Strategies - 2016, provides drug ... The research answers the following questions: What are ... are they positioned in the Global Uterine cancer market? ...
(Date:2/20/2017)... Feb. 20, 2017   MedPlast, Inc. , ... industry, announced today that it has signed a ... Device Manufacturing Services business.   The acquisition broadens MedPlast,s ... a leading services provider to the world,s largest ... further expand the company,s capabilities in assembly and ...
Breaking Medicine Technology: